Our existing guide to rehab costs and alcohol rehab cost breakdown cover what you can expect to pay by level of care. This piece answers a different question: why does the addiction treatment industry itself allow prices to vary so dramatically for what often looks, on paper, like a similar service? The answer has less to do with any individual facility's honesty and more to do with structural features of how this specific industry is regulated, owned, and priced.
Unlike some categories of medical care where procedures are billed using narrowly defined codes tied to relatively standardized services, "30 days of residential addiction treatment" can describe an enormous range of actual clinical content: different staff-to-patient ratios, different amounts of individual versus group therapy, different amenities, different levels of medical oversight. No federal agency publishes a standardized addiction treatment price list the way it might for some other categories of care, which means facilities set their own rates largely independent of any external pricing benchmark, constrained mainly by what insurers will negotiate and what the private-pay market will bear.
According to 2026 industry analysis of the addiction treatment M&A market, commercial insurance reimbursement for residential addiction treatment can reach $800 to $1,500 or more per day per bed under federal parity requirements, with partial hospitalization program rates commonly running $400 to $900 per day. These are genuinely high reimbursement rates relative to many other outpatient behavioral health settings, and they exist specifically because the Mental Health Parity and Addiction Equity Act requires insurers to cover addiction treatment comparably to medical care. High reimbursement rates create strong financial incentive for facilities to expand capacity and for investors to enter the market, which shapes pricing dynamics well beyond what any single facility's actual cost of care would otherwise suggest.
As of a 2024 analysis, private equity firms owned roughly 7 percent of substance use disorder treatment facilities nationally, following a decade of acquisition activity that brought over 1,100 facilities under private equity ownership. Research published in JAMA Psychiatry examining this trend found private equity-owned behavioral health and addiction treatment facilities charge more for care than comparably situated non-private-equity facilities. Separate research has also found a decline in the quality of buprenorphine treatment following private equity acquisition of a provider. This is not a claim that private equity ownership is inherently disqualifying, many private equity-backed facilities provide excellent care, but it is a documented, measurable factor contributing to price variation across the industry that has nothing to do with the actual clinical content of care at any given facility.
The deal economics behind this trend are worth understanding, since they explain why this consolidation has been attractive to investors in the first place. Industry M&A analysis notes that residential addiction treatment centers typically sell for 5 to 8 times EBITDA, with programs holding accreditation and a favorable, commercial-dominant payer mix commanding the higher end of that range. High commercial reimbursement rates, combined with the chronic, recurring nature of addiction as a condition requiring ongoing care, create financial dynamics that have made this sector an active target for acquisition and consolidation, a dynamic that shapes pricing pressure well beyond what any individual facility's costs would otherwise dictate.
For years, a subset of addiction treatment facilities billed insurance out-of-network at dramatically elevated rates, a practice that has faced significant regulatory and payer scrutiny more recently. According to 2026 industry M&A analysis, buyers evaluating facility acquisitions are now specifically cautious about revenue concentrated in out-of-network billing that does not meet ACA price transparency requirements, reflecting how much this practice has come under scrutiny. This history is part of why sticker prices you might encounter for a given facility can vary so widely depending on whether that facility is billing in-network, where a negotiated rate applies, or out-of-network, where the facility has historically had far more latitude to set its own price.
This billing distinction is worth understanding in practical terms, since it directly affects your out-of-pocket exposure regardless of a facility's overall reputation. An in-network facility has already agreed to a negotiated rate with your specific insurer, meaning your deductible and coinsurance apply to that agreed-upon amount. An out-of-network facility has no such agreement, meaning the facility can bill essentially whatever it chooses, and depending on your specific plan's out-of-network benefits, you could be responsible for the difference between what your insurer is willing to reimburse and what the facility actually charges, a gap that can be substantial. This is one of the single most consequential questions to ask before committing to any facility, and it explains a meaningful share of the price variation you will encounter when comparing options.
| Structural Feature | Effect on Pricing |
|---|
| Highly fragmented ownership (large numbers of independent, regional operators) | No dominant pricing benchmark exists; each facility essentially sets its own rate |
| 42.5 percent of facilities are private for-profit entities | Pricing reflects business strategy and market positioning, not solely cost of care |
| Growing but still modest private equity consolidation (roughly 7 percent of facilities) | Consolidated, investor-backed facilities tend to price higher, according to published research |
| Weak, inconsistent regulatory oversight nationally | Facilities operate with considerable latitude in how they structure and disclose pricing |
Price alone tells you very little about clinical quality in this specific industry, which is a meaningfully different situation than in many other areas of healthcare where price and standardization are more closely linked. A higher price can reflect genuinely superior staffing ratios and clinical programming, or it can reflect a facility's ownership structure, marketing spend, or historical out-of-network billing practices, with no reliable way to distinguish between these from the price tag alone. This is precisely why our guide to choosing a rehab center emphasizes accreditation, clinical outcomes data where available, and specific staffing and treatment model details over price as the primary factors in evaluating a facility.
It is also worth recognizing that this pricing opacity is not unique to a handful of bad actors within an otherwise transparent industry; it reflects a structural feature of the industry as a whole, one that even well-intentioned, high-quality facilities operate within. A facility charging a premium price is not automatically suspect, and a lower-priced facility is not automatically a bargain in disguise for a lesser product. The honest takeaway is that price, in this specific market, functions less as a reliable quality signal than it does in many other consumer categories, which is precisely why the specific, concrete questions below matter more than comparing sticker prices alone.
Consider two 30-day residential programs, one priced at $8,000 and another at $25,000, both treating a similar clinical population with similar levels of care on paper. The price difference might reflect a genuine difference in staff-to-patient ratio and individual therapy hours, a legitimate reason for higher cost. It might also reflect that the more expensive facility is privately equity-owned with correspondingly aggressive pricing, or that it historically relied more heavily on out-of-network billing before recent regulatory scrutiny. Without asking specific, concrete questions, staffing ratios, ownership structure, accreditation status, in-network billing practices, a family cannot reliably tell which explanation applies, which is exactly why price comparison alone is such an unreliable way to evaluate treatment options in this particular industry.
- What is your staff-to-patient ratio, and how much individual (not just group) therapy time is included?
- Is this facility independently owned, part of a regional group, or owned by a private equity firm or larger consolidator?
- Are you billing in-network with my specific insurance plan, or out-of-network?
- What accreditation do you hold, and can you share any available data on treatment outcomes or retention?
Our guide to insurance coverage for rehab covers how in-network versus out-of-network billing changes your actual cost, and our guide to paying for rehab without insurance outlines lower-cost paths if the private, insurance-driven market described here does not fit your budget.
Frequently asked questions
No federal agency publishes a standardized addiction treatment price list, and 'residential treatment' can describe widely varying actual clinical content, so facilities set their own rates largely independent of an external pricing benchmark.
Research published in JAMA Psychiatry found private equity-owned behavioral health and addiction treatment facilities charge more than comparable non-private-equity facilities, and roughly 7 percent of facilities nationally are now private equity-owned.
Federal parity law requires comparable coverage to medical care, and industry analysis shows residential treatment reimbursement can reach $800 to $1,500 or more per day per bed, creating strong financial incentive that shapes market pricing broadly.
Not reliably. A higher price can reflect genuinely superior staffing and programming, or it can reflect ownership structure, marketing spend, or billing practices, with no reliable way to distinguish between these from price alone.
A subset of facilities historically billed insurance out-of-network at dramatically elevated rates. This practice has faced significant regulatory scrutiny, and buyers evaluating facility acquisitions are now cautious about revenue concentrated in this billing type.
Ask about staff-to-patient ratio and individual therapy hours, ownership structure, whether they bill in-network with your specific plan, and their accreditation and any available outcomes data.
This article was reviewed by the RehabsNearMe Editorial Team for accuracy, clarity, and relevance. Information may be sourced from publicly available treatment resources, government agencies, and healthcare references where applicable.
Last reviewed: September 2026
Related articles
Resources
